2025 HCPCS Code Q5155
Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
| Short Description | Inj, aflibercept-jbvf, 1 mg |
| HCPCS Action Code | A - Add procedure or modifier code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | October 01, 2025 |
| HCPCS Action Effective Date | October 01, 2025 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q5006 - Hospice in hospice facility
- Q5007 - Hospice in ltch
- Q5008 - Hospice in inpatient psych
- Q5009 - Hospice/home hlth, place nos
- Q5010 - Hospice home care in hospice
- Q5098 - Inj ustekinumab-srlf, 1 mg
- Q5099 - Inj ustekinumab-stba, 1 mg
- Q5100 - Inj ustekinumab-kfce, 1 mg
- Q5101 - Injection, zarxio
- Q5102 - Inj., infliximab biosimilar
- Q5103 - Injection, inflectra
- Q5104 - Injection, renflexis
- Q5105 - Inj retacrit esrd on dialysi
- Q5106 - Inj retacrit non-esrd use
- Q5107 - Inj mvasi 10 mg
- Q5108 - Injection, fulphila
- Q5109 - Injection, ixifi, 10 mg
- Q5110 - Nivestym
- Q5111 - Injection, udenyca 0.5 mg
- Q5112 - Inj ontruzant 10 mg